MetLife Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
45,859
+1
| +0% | +$2 | ﹤0.01% | 2480 |
|
|
2025
Q1 | $306K | Buy |
45,858
+5,371
| +13% | +$35.8K | ﹤0.01% | 1964 |
|
|
2024
Q4 | $509K | Buy |
40,487
+2,986
| +8% | +$37.5K | ﹤0.01% | 1788 |
|
|
2024
Q3 | $693K | Hold |
37,501
| – | – | ﹤0.01% | 1601 |
|
|
2024
Q2 | $807K | Buy |
37,501
+4,498
| +14% | +$96.8K | ﹤0.01% | 1461 |
|
|
2024
Q1 | $889K | Hold |
33,003
| – | – | 0.01% | 1364 |
|
|
2023
Q4 | $989K | Buy |
33,003
+4,097
| +14% | +$123K | 0.01% | 1299 |
|
|
2023
Q3 | $592K | Hold |
28,906
| – | – | ﹤0.01% | 1526 |
|
|
2023
Q2 | $574K | Buy |
28,906
+720
| +3% | +$14.3K | ﹤0.01% | 1601 |
|
|
2023
Q1 | $483K | Hold |
28,186
| – | – | ﹤0.01% | 1667 |
|
|
2022
Q4 | $552K | Buy |
28,186
+5,211
| +23% | +$102K | ﹤0.01% | 1578 |
|
|
2022
Q3 | $367K | Hold |
22,975
| – | – | ﹤0.01% | 1863 |
|
|
2022
Q2 | $316K | Hold |
22,975
| – | – | ﹤0.01% | 1986 |
|
|
2022
Q1 | $364K | Buy |
22,975
+8,301
| +57% | +$132K | ﹤0.01% | 1973 |
|
|
2021
Q4 | $320K | Hold |
14,674
| – | – | ﹤0.01% | 1771 |
|
|
2021
Q3 | $439K | Hold |
14,674
| – | – | ﹤0.01% | 1596 |
|
|
2021
Q2 | $650K | Hold |
14,674
| – | – | 0.01% | 1421 |
|
|
2021
Q1 | $651K | Hold |
14,674
| – | – | 0.01% | 1377 |
|
|
2020
Q4 | $805K | Hold |
14,674
| – | – | 0.01% | 1229 |
|
|
2020
Q3 | $335K | Hold |
14,674
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q2 | $307K | Hold |
14,674
| – | – | ﹤0.01% | 1641 |
|
|
2020
Q1 | $205K | Hold |
14,674
| – | – | ﹤0.01% | 1684 |
|
|
2019
Q4 | $334K | Hold |
14,674
| – | – | ﹤0.01% | 1676 |
|
|
2019
Q3 | $171K | Hold |
14,674
| – | – | ﹤0.01% | 2030 |
|
|
2019
Q2 | $220K | Buy |
14,674
+4,192
| +40% | +$62.9K | ﹤0.01% | 1975 |
|
|
2019
Q1 | $184K | Hold |
10,482
| – | – | ﹤0.01% | 2021 |
|
|
2018
Q4 | $155K | Hold |
10,482
| – | – | ﹤0.01% | 2053 |
|
|
2018
Q3 | $258K | Buy |
+10,482
| New | +$258K | ﹤0.01% | 1945 |
|